A 10-year evaluation of prospective flow cytometry crossmatching. Risk of rejection and kidney graft loss in antibody positive patients.

被引:0
|
作者
Scornik, JC [1 ]
Patton, PR [1 ]
Van der Werf, WJ [1 ]
Hemming, AW [1 ]
Reed, AI [1 ]
Silkensen, JA [1 ]
Howard, RJ [1 ]
机构
[1] Univ Florida, Coll Med, Gainesville, FL USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
119
引用
收藏
页码:S143 / S143
页数:1
相关论文
共 10 条
  • [1] The use of flow cytomtery crossmatching to aid assessment of the risk of graft failure in donor specifc antibody positive patients
    Blow, S.
    Worthington, J.
    Martin, S.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2013, 40 (05) : 405 - 406
  • [2] ASSOCIATION OF SUBCLINICAL KIDNEY TRANSPLANT REJECTION WITH 10-YEAR ALL CAUSE GRAFT LOSS: AN ANALYSIS OF THE CTOT-08 STUDY
    Fleming, James
    Zhao, Lihui
    Friedewald, John
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [3] Galectin-3 and Risk of Late Graft Failure in Kidney Transplant Recipients: A 10-year Prospective Cohort Study
    Sotomayor, Camilo G.
    Te Velde-Keyzer, Charlotte A.
    Diepstra, Arjan
    van Londen, Marco
    Pol, Robert A.
    Post, Adrian
    Gans, Rijk O. B.
    Nolte, Ilja M.
    Slart, Riemer H. J. A.
    de Borst, Martin H.
    Berger, Stefan P.
    Rodrigo, Ramon
    Navis, Gerjan J.
    de Boer, Rudolf A.
    Bakker, Stephan J. L.
    TRANSPLANTATION, 2021, 105 (05) : 1106 - 1115
  • [4] Flow cytometry crossmatching to investigate kidney-biopsy-proven, antibody-mediated rejection in patients who develop de novo donor-specific antibodies
    Usureau, Cedric
    Jacob, Valentine
    Clichet, Valentin
    Presne, Claire
    Desoutter, Judith
    Poulain, Coralie
    Choukroun, Gabriel
    Guillaume, Nicolas
    TRANSPLANT IMMUNOLOGY, 2020, 61
  • [5] New Onset Diabetes after Kidney Transplant Is Associated With Increased Risk of Graft Loss and Death at 10-Year Follow-Up
    Tong, Jenny
    Shields, Adele
    Hanseman, Dennis
    Alloway, Rita R.
    Woodle, E. Steve
    DIABETES, 2013, 62 : A451 - A451
  • [6] ADDITION OF RITUXIMAB TO INDUCTION THERAPY DECREASES RISK OF ANTIBODY-MEDIATED REJECTION AND GRAFT LOSS IN RENAL TRANSPLANT RECIPIENTS WITH POSITIVE FLOW CROSSMATCH AND DONOR SPECIFIC ANTIBODIES
    Anwar, Siddiq
    Horwedel, Timothy
    Ashraf, Muhammad
    Khalid, Syed
    Brennan, Daniel
    Klein, Christina
    TRANSPLANT INTERNATIONAL, 2013, 26 : 79 - 79
  • [7] Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis
    Pilecki, Tomasz
    Czarkowska-Paczek, Bozena
    Lisik, Wojciech
    Nazarewski, Slawomir
    Paczek, Leszek
    ANNALS OF TRANSPLANTATION, 2023, 28
  • [8] Risk factors for antibody mediated rejection (AMR) in kidney transplant (KTX) recipients with positive CDC B-cell/flow cytometry crossmatch (CXM) treated with low dose intravenous immunoglobulin (IVIG) and rATG therapy
    Moss, Adyr
    Heilman, R.
    Chakkera, H.
    Mazur, M.
    Petrides, S.
    Wosniak, E.
    Mekeel, K.
    Mulligan, D.
    Reddy, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 356 - 357
  • [9] Evaluation of drug utilization pattern of antidiabetic drugs and 10-year cardiovascular risk in new and recently diagnosed type 2 diabetes mellitus patients: a prospective, longitudinal, observational, hospital-based study
    J. K. Mehta
    S. P. Dhaneria
    N. R. Gaikwad
    Y. N. Keche
    P. N. Wasnik
    M. S. Siddiqui
    International Journal of Diabetes in Developing Countries, 2023, 43 : 59 - 65
  • [10] Evaluation of drug utilization pattern of antidiabetic drugs and 10-year cardiovascular risk in new and recently diagnosed type 2 diabetes mellitus patients: a prospective, longitudinal, observational, hospital-based study
    Mehta, J. K.
    Dhaneria, S. P.
    Gaikwad, N. R.
    Keche, Y. N.
    Wasnik, P. N.
    Siddiqui, M. S.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2023, 43 (01) : 59 - 65